Basel Medical Group Ltd (BMGL)
NASDAQ · Healthcare
Basel Medical Group Ltd Shareholder Equity 2022–2025
Basel Medical Group Ltd annual shareholder equity history from 2022 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Basel Medical Group Ltd shareholder equity as of June 30, 2025: 5.4M, a 28.08% decrease year-over-year.
- Basel Medical Group Ltd shareholder equity for 2025 were 5.4M, a 28.08% decrease from 2024.
- Basel Medical Group Ltd shareholder equity for 2024 were 7.6M, a 37.76% increase from 2023.
- Basel Medical Group Ltd shareholder equity for 2023 were 5.5M, a 93.67% increase from 2022.
- Basel Medical Group Ltd shareholder equity for 2022 were 2.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Basel Medical Group Ltd Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $5 |
| 2024 | $8 |
| 2023 | $5 |
| 2022 | $3 |
Basel Medical Group Ltd Shareholder Equity — FAQ
Basel Medical Group Ltd (BMGL) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMGL's shareholder equity history?
The chart and table above show Basel Medical Group Ltd's shareholder equity by year and by quarter, including the growth rate.